Abstract

Early detection of inflammatory joint diseases is very important to allow prompt initiation of effective therapies. Identifying patients with early arthritic disease can be challenging by conventional clinical, laboratory and radiographic methods, and more advanced imaging modalities such as computed tomography (CT), magnetic resonance imaging, ultrasonography (US) and various nuclear medicine techniques can provide additional information.

This talk describes the current knowledge on the value of different imaging modalities for 1) predicting development of psoriatic disease in undifferentiated patients 2) predicting development of psoriatic arthritis (PsA) in patients with psoriasis with and without musculoskeletal pain and 3) predicting the disease course in patients with PsA.